Allergy Therapeutics Share Discussion Threads

[coinbase] 14/10/2021 10:45

Fantastic news!

[petewy] 11/10/2021 12:12

buys going thru as sells

[farmergeorge] 08/10/2021 11:27

Thanks coinbase.

[farmergeorge] 07/10/2021 11:23

Ok, thanks. Yes I agree, the wording is interesting.

[jimmyloser] 07/10/2021 11:23

FG
It was a part of the Prelims. I think the wording is really interesting. IMPO

[farmergeorge] 07/10/2021 11:16

jl, what is date and source of this? Thanks.

[farmergeorge] 07/10/2021 11:04

Nice encouraging news jl. Thanks for that.

[jimmyloser] 07/10/2021 10:50

impo, this is very upbeat and nicely written.............Distribution deals?


Mild allergy - a new market segment

ImmunoBON, the novel, patented protein-based oral product, which mimics the so-called 'farm effect', has made a strong start in our German and Austrian commercial markets. While sales of ImmunoBON are not yet material to the business, the product has significant potential across Europe and in major pharmaceutical markets worldwide.

ImmunoBON provides not only relief for a wide variety of allergies, but also targets mild allergy patients, providing Allergy Therapeutics with a commercial product in the largest segment of the allergy market as an over-the-counter product. The product also has the advantages of being natural and, with a relatively short treatment period of three months, offers the potential for higher patient compliance compared to longer course allergy treatments. Existing early data support its use as a treatment for birch and house dust mite allergies and the Group is exploring its potential against grass, cat, dog and horse allergies.

[coinbase] 06/10/2021 16:40

L2: 3 (1,050,000 @ 37) v 5 (50,000 @ 38).

[mighunter] 24/9/2021 21:20

AGY got second mention on Vox markets podcast with Vadim Alexandre. HTtps://www.voxmarkets.co.uk/articles/vadim-alexandre-discusses-polarean-imaging-allergy-therapeutics-41d8179/

[jbuchanan1] 24/9/2021 17:13

How are they going to do the NASDAQ listing? Its mentioned in the RNS. Surely that will be good for the AIM share price. Any insight welcome. Thx

[nearlythere] 23/9/2021 09:07

It looks like the next 12 to 24 months will be pivotal. The approval process is time consuming although at least the funding is already in place. If all goes as planned then IMO a take over maybe likely later.

All IMO DYOR

[slopsjon2] 23/9/2021 07:39

Finncap have released a note raising their target price to 50p from 45p.

[wizzkid211] 23/9/2021 07:13

Preliminary Results for the Year ended 30 June 2021

- Record pre-R&D operating profit ahead of market expectations reflecting continued sales growth

- Successful ex-vivo VLP Peanut biomarker study showing 24-fold reduction in allergenicity and beneficial efficacy profile paving the way for first-in-human trial in 2022

- Strong cash balance of GBP40.3m providing sufficient funds with a small amount of debt under current assumptions to support Grass MATA MPL pivotal Phase III field studies and Phase I VLP Peanut PROTECT trial

[jimmyloser] 22/9/2021 17:04

I am expecting a subdued outlook statement tomorrow along with further distribution news on the farmyard product impoAny other views?

[coinbase] 21/9/2021 15:18

DMA: 10,000 @ 37.94.

[richtea2517] 21/9/2021 14:57

Nice looking rise this

[coinbase] 21/9/2021 14:17

DMA: 10,000 @ 37.49.

[coinbase] 21/9/2021 14:14

L2: 5 (50,000 @ 36) v 2 (20,000 @ 37.50).

[coinbase] 21/9/2021 14:08

L2 is strengthening.